Tower Research Capital LLC (Trc) Aim Immuno Tech Inc. Transaction History
Tower Research Capital LLC (Trc)
- $5.8 Billion
- Q2 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 26,728 shares of AIM stock, worth $6,682. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,728
Previous 18,183
46.99%
Holding current value
$6,682
Previous $8,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AIM
# of Institutions
39Shares Held
8.44MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY4.08MShares$1.02 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.99MShares$497,1760.0% of portfolio
-
Black Rock Inc. New York, NY698KShares$174,5660.0% of portfolio
-
Geode Capital Management, LLC Boston, MA401KShares$100,2560.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny229KShares$57,2020.0% of portfolio
About AIM ImmunoTech Inc.
- Ticker AIM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,049,300
- Market Cap $12M
- Description
- AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...